Updated Jul 16, 2026
McGroddy-Goetz Kathleen has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Kathleen McGroddy-Goetz is listed as a director of Tandem Diabetes Care Inc. in the company’s SEC filings as of May 22, 2026. The filings identify her role as a director on the Tandem Diabetes Care board. Additional publicly disclosed details about her education, career history, and other board positions are not available in the provided SEC context.
| Role | Director |
|---|---|
| Notability | 60/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-22 | TNDM | TANDEM DIABETES CARE INC | M — Option exercise | 8.8K | $0.00 |
Kathleen McGroddy-Goetz is listed as a director of Tandem Diabetes Care Inc. in the company’s SEC filings as of May 22, 2026. The filings identify her role as a director on the Tandem Diabetes Care board. Additional publicly disclosed details about her education, career history, and other board positions are not available in the provided SEC context.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live McGroddy-Goetz Kathleen profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.